Related Experiment Videos
Underlying disorders associated with severe early-onset preeclampsia
G A Dekker1, J I de Vries, P M Doelitzsch
1Department of Obstetrics and Gynecology, Free University Hospital, Amsterdam, The Netherlands.
American Journal of Obstetrics and Gynecology
|October 1, 1995
Summary
Women with severe early-onset preeclampsia often have clotting and metabolic issues. Screening for protein S deficiency, hyperhomocysteinemia, and anticardiolipin antibodies is recommended for future pregnancy management.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Metabolic Disorders
Background:
- Severe early-onset preeclampsia is linked to an increased risk of vascular thrombosis.
- Understanding underlying hemostatic and metabolic abnormalities is crucial for patient management.
Purpose of the Study:
- To investigate hemostatic and metabolic abnormalities in patients with a history of severe early-onset preeclampsia.
- To determine associations with a tendency for vascular thrombosis.
Main Methods:
- A cohort of 101 patients with severe early-onset preeclampsia were evaluated post partum.
- Tests included hyperhomocysteinemia (methionine loading test), protein S deficiency, activated protein C resistance, and anticardiolipin antibodies.
Main Results:
- Protein S deficiency was found in 24.7% of tested patients.
- Hyperhomocysteinemia was present in 17.7%, activated protein C resistance in 16.0%, and anticardiolipin antibodies in 29.4%.
Conclusions:
- Patients with severe early-onset preeclampsia show a high prevalence of clotting and metabolic abnormalities.
- Screening for protein S deficiency, hyperhomocysteinemia, activated protein C resistance, and anticardiolipin antibodies is advised for future pregnancy counseling and management.